We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Discussion of Lung Adenocarcinoma Effectively Treated with Erlotinib: A Case Investigation.
- Authors
Fujita, Yoshitsugu; Mineshita, Masamichi; Kida, Hirotaka; Handa, Hiroshi; Ishikawa, Fuzuki; Oshige, Masahiro; Miyazawa, Teruomi; Eguchi, Kenji; Seki, Nobuhiko; Inoue, Ken
- Abstract
Introduction: The current reality is that the usage of gefitinib and erlotinib, two molecularly targeted drugs to treat advanced non-small cell lung cancer, has not been clearly delineated. Here, we report a case of lung adenocarcinoma in which the patient developed resistance to gefitinib but later erlotinib therapy proved to be effective. Discussion: Erlotinib is an oral agent and is also beneficial in terms of QOL.
- Subjects
ANTINEOPLASTIC agents; LUNG tumors; HEALTH outcome assessment; TREATMENT effectiveness; DRUG therapy
- Publication
International Medical Journal, 2010, Vol 17, Issue 3, p236
- ISSN
1341-2051
- Publication type
Article